
ALPS · NASDAQ
Alps Group Inc
$0.32 0.00 (-0.34%)
Company overview
Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predictive, preventive, and precision medicine.
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Market cap
- $53.2M
- Employees
- 2
- Headquarters
- Kuala Lumpur
- Website
- alps-holdings.com
- CEO
- Seng Kong Tham
- Listed
- October 31, 2025
- P/E
- -0.78
- Dividend yield
- 0.00%
Company financials
- Revenue
- $3.4M
- Gross profit
- $1.3M
- Operating income
- -$66.8M
- EBITDA
- -$66.9M
- Net income
- -$67.6M
- EPS
- -$0.41
- Total assets
- $1.7M
- Total debt
- $5.9M
- Gross margin
- 38.60%
- Net margin
- -2,004.52%
- Earnings yield
- -128.13%